Shen, Y. .; Chen, X. .; Zhang, H. .; Hu, . H. Long-Term Cost-Effectiveness Analysis of onceweekly Semaglutide Versus Dulaglutide for the Treatment of Type 2 Diabetes After the Renewal of the National Drug Reimbursement List in China. Health Decision 2024, 2.